Monday |
Work on experimental medicine study protocol |
Teleconference with FDA to discuss design of a drug–drug interaction study during phase III development |
Tuesday |
Project team meeting to design early-phase development plan for a new chemical entity |
Wednesday |
Present development proposals to internal multidisciplinary management group |
Review report of a serious adverse event from a current study; speak to investigator to obtain additional information; prepare report and discuss with safety department |
Thursday |
Work on a study report for a recently completed phase II study |
Meet with external academic expert to discuss design of experimental medicine study |
Friday |
Chair dose escalation meeting for first-in-man study currently in progress |
Review headline data from recently completed phase II study |
Weekend and evenings |
On call for medical advice for current clinical studies; prepare abstracts/manuscripts of completed studies |